Companies · Healthtech

Eleanor Health Holdings, Llc

WALTHAM · Healthtech · refined from filed group “Other

Diligence memoA one-page analyst read on Eleanor Health Holdings, Llc — recommendation, valuation, rhythm, risks.
$138.0M
Total raised · real
5
Rounds
0.3×
Latest step-up
Top 4%
Sector rank · raised
Series C
Latest stage · inferred · Fri Feb 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Eleanor Health Holdings, Llc looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.43× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era.
At-risk
  • Last raise 2.4 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Eleanor Health Holdings, Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
7.0 yr record
Peak capital year was 2022 with $78.6M across 1 filings.
Market position
ahead of 97% of Healthtech peers
Capital scale is ahead of 97% of Healthtech peers; modeled value is above 87% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2022: $78.6M across 1 filings.
  • Largest single filing was $78.6M on 2022-03-30.
  • Filing rows sum to $150.0M, while canonical raised total is $138.0M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Eleanor Health Holdings, Llc is one of 2138 Healthtech companies tracked from WALTHAM. By capital raised it ranks among the largest (ahead of 97% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
19
Investors (latest)
2019
Year incorporated
2024-02-09
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries A · 2019-07-10 Raised $12M (real) Modeled valuation $271M (est)Series A2019Series A · 2019-07-10 Raised $4.5M (real) Modeled valuation $102M (est)Series A2019Series A · 2019-07-10 Raised $7.5M (real) Modeled valuation $169M (est)Series A2019Series A · 2020-02-19 Raised $3.1M (real) Modeled valuation $71M (est)Series A2020Series B · 2021-05-12 Raised $22M (real) Modeled valuation $414M (est)Series B2021Series C · 2022-03-30 Raised $79M (real) Modeled valuation $1.2B (est)Series C2022Series C · 2024-02-09 Raised $22M (real) Modeled valuation $210M (est)Series C2024+$4.5M+$7.5M+$3.1M+$22M+$79M+$22MCumulative $150M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$12.0M · 2019
Series A extension$4.5M · 2019
Series A extension$7.5M · 2019
Series A extension$3.1M · 2020
Series B$22.1M · 2021
Series C$78.6M · 2022
Series C extension$22.2M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.

Modeled valuation trajectory
$210.3M
Base estimate est.
$80.8M
Conservative case
$337.3M
Upside case
$148.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $270.9M · 2019-07-102019Series A · modeled $101.6M · 2019-07-10Series A · modeled $169.3M · 2019-07-10Series A · modeled $70.5M · 2020-02-19Series B · modeled $413.9M · 2021-05-12Series C · modeled $1.2B · 2022-03-30Series C · modeled $210.3M · 2024-02-092024
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
2.4 yr
Elapsed time used
2.4 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
9 mo
Avg between rounds
$30.1M/yr
Capital velocity
7.0 yr
On record since
2019
First round
7
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 31× above median
This company$138.0M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.5× of median
This company$22.2M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 6.2× above median
This company$210.3M
Sector median$33.8M

Raised more than 97% of sector peers (real $). Modeled value above 87% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #31 of 39.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Freedom Dental Funding, LLC · Series C Raised $100.0M · modeled $1.1B (est)Elevate Care International Topco LP · Series C Raised $98.4M · modeled $1.0B (est)Athelas Inc. · Series C Raised $54.4M · modeled $903.4M (est)Hazel Health, Inc. · Series C Raised $86.0M · modeled $817.6M (est)Health Gorilla, Inc. · Series C Raised $58.7M · modeled $816.3M (est)Employee Health Holdings, LP · Series C Raised $78.8M · modeled $779.7M (est)Magnolia Medical Technologies, Inc. · Series C Raised $94.2M · modeled $728.3M (est)Allied Health MSO Holdco, LLC · Series C Raised $62.8M · modeled $724.9M (est)Pearl Health, Inc. · Series C Raised $55.5M · modeled $721.8M (est)Veridian Healthcare Holdings LLC · Series C Raised $63.0M · modeled $692.5M (est)Accompany Health, Inc. · Series C Raised $56.3M · modeled $680.7M (est)Alleviant Medical, Inc. · Series C Raised $148.8M · modeled $677.4M (est)Eleanor Health Holdings, Llc (this company) Raised $138.0M · modeled $210.3M (est)Eleanor Health Holdings, Llc
CompanyStageRaised · realValue · estvs peer med.
Freedom Dental Funding, LLCSeries C$100.0M$1.1B2.33×
Elevate Care International Topco LPSeries C$98.4M$1.0B2.07×
Athelas Inc.Series C$54.4M$903.4M1.86×
Hazel Health, Inc.Series C$86.0M$817.6M1.68×
Health Gorilla, Inc.Series C$58.7M$816.3M1.68×
Employee Health Holdings, LPSeries C$78.8M$779.7M1.60×
Magnolia Medical Technologies, Inc.Series C$94.2M$728.3M1.50×
Allied Health MSO Holdco, LLCSeries C$62.8M$724.9M1.49×
Pearl Health, Inc.Series C$55.5M$721.8M1.48×
Veridian Healthcare Holdings LLCSeries C$63.0M$692.5M1.42×
Accompany Health, Inc.Series C$56.3M$680.7M1.40×
Alleviant Medical, Inc.Series C$148.8M$677.4M1.39×
Eleanor Health Holdings, Llc this companySeries C$138.0M$210.3M0.43×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$12.0M2019-07-10$54.5M$270.9M90%
Series A$4.5M2019-07-10$20.5M$101.6M90%
Series A$7.5M2019-07-10$34.1M$169.3M90%
Series A$3.1M2020-02-19$14.2M$70.5M90%
Series B$22.1M2021-05-12$122.6M$413.9M90%
Series C$78.6M2022-03-30$523.9M$1.2B90%
Series C$22.2M2024-02-09$148.2M$210.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$12.0M2019-07-10
    • First recorded raise — entered as Series A.
    • 3 investors on this round.
  2. Series A$4.5M2019-07-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.7× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  3. Series A$7.5M2019-07-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× larger than the prior — scaling up.
    • 2 investors on this round.
  4. Series A$3.1M2020-02-19
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 2.4× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  5. Series B$22.1M2021-05-12
    • Raised 15 mo later, in step with the ~14 mo sector norm.
    • Round 7.1× larger than the prior — scaling up.
    • 8 investors on this round.
  6. Series C$78.6M2022-03-30
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 3.6× larger than the prior — scaling up.
    • 7 investors on this round.
  7. Series C$22.2M2024-02-09
    • Raised again after 22 mo — slower than the ~14 mo sector norm.
    • Round 3.5× smaller than the prior — bridge or down round.
    • 19 investors on this round.
Intelligence
2024 ~Q4
Modeled next raise · ~9mo cadence
$22.2M
Modeled next size est.range $22.2M$35.6M
0.3×
Last step-up
$30.1M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Whelan4 other2019-07
Jessica Zeaske4 other2022-03
Chris Bischoff3 other2022-03
Trevor Price3 other2019-07
Andy Slavitt2 other2019-07
Candace Richardson2 other2024-02
Rachel Winokur2 other2022-03
CHRISTINA MAINELLI1 other2022-03
Christopher Bischoff1 other2024-02
CORBIN PETRO2019-07
Kate Hobbs Knutson2019-07
Kurt Sheline2019-07
Kyle Raffianello2022-03
NZINGA HARRISON2019-07
Scott Fries2024-02
Sonny Goyal2019-07
Srishti Mirchandani2019-07
William McKinney2024-02
Registry & provenance

Eleanor Health Holdings, Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1783164
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Hopscotch Health Holdings, LlcHealthtechSeries C$110.0M$101.9Mnetwork1 shared operator · same sector · same stage
Genome Medical Holding CoHealthtechSeries C$90.0M$606.2Mnetwork1 shared operator · same sector · same stage
Thyme Care, Inc.HealthtechSeries C$214.3M$668.4Mnetwork1 shared operator · same sector · same stage
Quartet Health Holdings, Inc.HealthtechSeries C$51.4M$883.1Mnetwork1 shared operator · same sector · same stage
HealthVerity, Inc.HealthtechSeries D+$146.2M$2.1Bnetwork1 shared operator · same sector
Journey Health Inc.HealthtechSeed$1.3M$34.7Mnetwork2 shared operators · same sector
ShockWave Medical, Inc.HealthtechSeries C$144.8M$255.8Msame sector · same stage
Conformal Medical, Inc.HealthtechSeries C$145.1M$200.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Como Health Holdings, LLCHealthtechSeed$10.2M85%
Bradford Health Holdings, LLCHealthtechSeries B$34.8M84%
Health Payment Holdings, LLCHealthtechSeed$55.5M84%
HealthChain Holdings LLCHealthtechPre-Seed$13.4M84%
Tri-State Medical Holdings LLCHealthtechSeed$22.2M84%
Consortia Health Holdings IncHealthtechSeed$73.5M84%
June Medical Holdings, LLCHealthtechPre-Seed$4.0M84%
Integrated Health Systems Holdings, LLCHealthtechSeries A$114.5M84%
Frequently asked
How much funding has Eleanor Health Holdings, Llc raised?
Eleanor Health Holdings, Llc has raised approximately $138.0M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Eleanor Health Holdings, Llc's estimated valuation?
Provath's modeled valuation for Eleanor Health Holdings, Llc is approximately $210.3M (modeled range $80.8M–$337.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Eleanor Health Holdings, Llc at?
Eleanor Health Holdings, Llc's latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Feb 09.
What does Eleanor Health Holdings, Llc do and where is it based?
Eleanor Health Holdings, Llc operates in the Healthtech sector, based in WALTHAM.
Explore related

See where Eleanor Health Holdings, Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Eleanor Health Holdings, Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.